The six-month mark is when many deficiencies cross from subclinical to clinical
T2DM treatment involves multiple parameters due to the complexity of managing the disease, which involve medications and comorbidities, patient lifestyle, profile, duration of the disease, site of action, pharmacological approaches, and adherence or persistence to medication
As research continues, many people are keen to understand how it works, the correct dosage and what results it might bring
Headquartered in Bagsvaerd, Denmark, Novo Nordisk was founded in 1923 specifically around insulin itself a peptide and has spent a century perfecting the science, manufacturing, and commercialisation of peptide therapeutics